Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil showed a 30% success rate for hair growth in a study, and various skin treatments were effective, but some had limitations or side effects.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Finasteride and dutasteride can improve hair loss in women, but more research is needed.

The Breast Utility Instrument was developed to assess quality of life in breast cancer patients.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Better supportive care is needed to manage chemotherapy side effects.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Common acne treatments can cause various side effects, like skin irritation and more serious issues, but combination therapies are often more effective and better tolerated.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

EGFR inhibitors cause skin issues and hair loss by weakening skin defenses, suggesting antibiotics and targeted treatments can help.

Cancer treatments often cause skin, nail, and hair problems.

Proton minibeam radiotherapy shows promise for sparing healthy tissue in cancer treatment but needs further research and technological development.

Cyproterone acetate can cause rare shortness of breath in women.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Left-handed men experience more sexual side effects from finasteride treatment.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Bioelectronic nanogenerators show promise for cancer treatment but need better understanding and development.